share_log

Interested In Xuchang KETOP Testing Research InstituteLtd's (SZSE:003008) Upcoming CN¥0.30 Dividend? You Have Four Days Left

Interested In Xuchang KETOP Testing Research InstituteLtd's (SZSE:003008) Upcoming CN¥0.30 Dividend? You Have Four Days Left

對許昌開拓測試研究所有限公司(深圳證券交易所:003008)即將派發的0.30元人民幣股息感興趣嗎?你還剩四天
Simply Wall St ·  05/22 19:44

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Xuchang KETOP Testing Research Institute Co.,Ltd (SZSE:003008) is about to trade ex-dividend in the next 4 days. The ex-dividend date is usually set to be one business day before the record date which is the cut-off date on which you must be present on the company's books as a shareholder in order to receive the dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Accordingly, Xuchang KETOP Testing Research InstituteLtd investors that purchase the stock on or after the 27th of May will not receive the dividend, which will be paid on the 27th of May.

熟悉我們的讀者都知道,我們喜歡分紅派息,因此看到開普檢測(股票代碼:003008.SZ)即將在接下來的4天內交易除息的消息令人興奮。除息日通常設定爲登記日前一業務日,即您必須作爲股東出現在公司賬簿上才能獲得股息的截止日期。除息日非常重要,因爲任何在股票上的交易都需要在登記日之前結算才能有資格獲得股息。因此,自5月27日以後購買開普檢測股票的投資者將無法獲得即將於5月27日支付的股息。

The company's upcoming dividend is CN¥0.30 a share, following on from the last 12 months, when the company distributed a total of CN¥0.30 per share to shareholders. Based on the last year's worth of payments, Xuchang KETOP Testing Research InstituteLtd has a trailing yield of 1.3% on the current stock price of CN¥22.31. Dividends are an important source of income to many shareholders, but the health of the business is crucial to maintaining those dividends. As a result, readers should always check whether Xuchang KETOP Testing Research InstituteLtd has been able to grow its dividends, or if the dividend might be cut.

公司即將分派的每股股息爲人民幣0.30元,上一年度公司向股東分配了總計人民幣0.30元的股息。根據去年的分紅,開普檢測在目前的股價22.31元人民幣上有1.3%的年度股息率。分紅是許多股東的重要收入來源,但企業的健康狀況對於維持這些股息至關重要。因此,讀者應始終檢查開普檢測是否能夠增加其股息或是否需要削減其股息。

Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. Fortunately Xuchang KETOP Testing Research InstituteLtd's payout ratio is modest, at just 43% of profit. Yet cash flow is typically more important than profit for assessing dividend sustainability, so we should always check if the company generated enough cash to afford its dividend. Dividends consumed 72% of the company's free cash flow last year, which is within a normal range for most dividend-paying organisations.

通常,股息是從公司的盈利中支付的。如果公司支付的股息超過其盈利,則股息可能是不可持續的。幸運的是,開普檢測的派息比率很適中,只有43%。然而,現金流通常比盈利更重要,以評估股息的可持續性,因此我們應始終檢查公司是否產生了足夠的現金來支付其股息。開普檢測去年的自由現金流消耗了公司自由現金流的72%,這是大多數分紅機構的正常區間。

It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.

看到股息既有盈利也有現金流的覆蓋是令人鼓舞的。這通常表明股息是可持續的,只要收益沒有急劇下降。

Click here to see how much of its profit Xuchang KETOP Testing Research InstituteLtd paid out over the last 12 months.

單擊此處,查看開普檢測上一年度支付的盈利比率。

historic-dividend
SZSE:003008 Historic Dividend May 22nd 2024
深圳證券交易所代碼:003008 歷史分紅:2024年5月22日

Have Earnings And Dividends Been Growing?

收益和股息一直在增長嗎?

Businesses with shrinking earnings are tricky from a dividend perspective. If earnings fall far enough, the company could be forced to cut its dividend. Xuchang KETOP Testing Research InstituteLtd's earnings per share have fallen at approximately 17% a year over the previous five years. When earnings per share fall, the maximum amount of dividends that can be paid also falls.

從股息的角度看,收益萎縮的企業很麻煩。如果收益下降得足夠快,公司可能會被迫削減股息。開普檢測的每股收益在過去五年中下降了約17%。當每股收益下降時,可以支付的最大股息金額也會下降。

The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. Xuchang KETOP Testing Research InstituteLtd's dividend payments per share have declined at 21% per year on average over the past three years, which is uninspiring. It's never nice to see earnings and dividends falling, but at least management has cut the dividend rather than potentially risk the company's health in an attempt to maintain it.

大多數投資者評估公司的股息前景的主要方式是檢查股息歷史增長率。開普檢測的每股股息支付,在過去三年中平均下降了21%,這並不令人鼓舞。看到收益和股息下降並不是件好事,但至少管理層已經削減了股息,而不是爲了維持股息而可能危及公司的健康。

Final Takeaway

最後的結論

From a dividend perspective, should investors buy or avoid Xuchang KETOP Testing Research InstituteLtd? Its earnings per share have been declining meaningfully, although it is paying out less than half its income and more than half its cash flow as dividends. Neither payout ratio appears an immediate concern, but we're concerned about the earnings. To summarise, Xuchang KETOP Testing Research InstituteLtd looks okay on this analysis, although it doesn't appear a stand-out opportunity.

從股息的角度看,投資者應該買還是避開開普檢測?其每股收益已經明顯下降,雖然其收入的支付比例不到一半,但其現金流的支付比例超過一半。支付比率似乎都不是立即的問題,但我們擔心收益。總之,開普檢測在這方面看起來還可以,但並不是一個傑出的機會。

With that being said, if dividends aren't your biggest concern with Xuchang KETOP Testing Research InstituteLtd, you should know about the other risks facing this business. We've identified 3 warning signs with Xuchang KETOP Testing Research InstituteLtd (at least 1 which makes us a bit uncomfortable), and understanding these should be part of your investment process.

話雖如此,如果分紅不是投資者最關心的問題,他們應該了解開普檢測業務面臨的其他風險。我們已經確認了開普檢測的三個警告信號(至少有一個讓我們感到有點不安),了解這些應該成爲您的投資過程的一部分。

A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.

一個常見的投資錯誤是購買你看到的第一個有趣的股票。在這裏,您可以找到高股息股票的完整列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論